The blood mSEPT9 is capable of assessing the surgical therapeutic effect and the prognosis of colorectal cancer

The performance of the mSEPT9 assay is influenced by algorithm, cancer stage and age, but not sex and cancer location

(2017) Lele Song et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

The SEPT9 gene methylation assay is capable of detecting colorectal adenoma in opportunistic screening

(2017) Lele Song et al.   Epigenomics

The performance of the SEPT9 gene methylation assay and a comparison with other CRC screening tests: A meta-analysis

(2017) Lele Song et al.   Scientific Reports

Localized Colon Cancer, Version 3.2013

(2017) Al B. Benson et al.   Journal of the National Comprehensive Cancer Network

Detection of Colorectal Cancer Using a Simplified SEPT9 Gene Methylation Assay Is a Reliable Method for Opportunistic Screening

(2016) Dong Wu et al.   JOURNAL OF MOLECULAR DIAGNOSTICS

Current noninvasive tests for colorectal cancer screening: An overview of colorectal cancer screening tests

(2016) Le-Le Song et al.   World Journal of Gastrointestinal Oncology

Individualized Mutation Detection in Circulating Tumor DNA for Monitoring Colorectal Tumor Burden Using a Cancer-Associated Gene Sequencing Panel

(2016) Kei A. Sato et al.   PLoS One

Application of Circulating Tumor DNA as a Non-Invasive Tool for Monitoring the Progression of Colorectal Cancer

(2016) Jiaolin Zhou et al.   PLoS One

Analysis of circulating tumour DNA to monitor disease burden following colorectal cancer surgery

(2015) Thomas Reinert et al.   GUT

Simultaneous Analysis of SEPT9 Promoter Methylation Status, Micronuclei Frequency, and Folate-Related Gene Polymorphisms: The Potential for a Novel Blood-Based Colorectal Cancer Biomarker

(2015) Gloria Ravegnini et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Performance of a second-generation methylated SEPT9 test in detecting colorectal neoplasm

(2015) Peng Jin et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Accuracy of Fecal Immunochemical Tests for Colorectal Cancer

(2014) Jeffrey K. Lee et al.   ANNALS OF INTERNAL MEDICINE

Detection of colorectal cancer by DNA methylation biomarker SEPT9: past, present and future

(2014) Yuemin Li et al.   Biomarkers in Medicine

Postoperative serum methylation levels ofTAC1andSEPT9are independent predictors of recurrence and survival of patients with colorectal cancer

(2014) CheeKian Tham et al.   CANCER

Validation of a Real-Time PCR-Based Qualitative Assay for the Detection of Methylated SEPT9 DNA in Human Plasma

(2014) N. T. Potter et al.   CLINICAL CHEMISTRY

Multitarget Stool DNA Testing for Colorectal-Cancer Screening

(2014) Thomas F. Imperiale et al.   NEW ENGLAND JOURNAL OF MEDICINE

Circulating Methylated Septin 9 Nucleic Acid in the Plasma of Patients with Gastrointestinal Cancer in the Stomach and Colon

(2014) Hye Seung Lee et al.   Translational Oncology

Quantitative detection of methylated NDRG4 gene as a candidate biomarker for diagnosis of colorectal cancer

(2014) WENHUA XIAO et al.   Oncology Letters

Prospective evaluation of methylatedSEPT9in plasma for detection of asymptomatic colorectal cancer

(2013) Timothy Robert Church et al.   GUT

DNA Methylation of the Homeobox Genes PITX2 and SHOX2 Predicts Outcome in Non–small-cell Lung Cancer Patients

(2012) Dimo Dietrich et al.   DIAGNOSTIC MOLECULAR PATHOLOGY

Detection of Methylated SEPT9 in Plasma Is a Reliable Screening Method for Both Left- and Right-Sided Colon Cancers

(2012) Kinga Tóth et al.   PLoS One

Septin 9 methylated DNA is a sensitive and specific blood test for colorectal cancer

(2011) Jorja D Warren et al.   BMC Medicine

Circulating mutant DNA to assess tumor dynamics

(2008) Frank Diehl et al.   NATURE MEDICINE